Overview

Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
To compare the hypothyroid state in patients with thyroid cancer prepared either by placebo or L-T3 following L-T4 withdrawal in preparation for whole body scintigraphy. To evaluate the time needed for TSH elevation (> 30 mUI/L) on placebo vs. L-T3.
Phase:
N/A
Details
Lead Sponsor:
Patrice Perron
Collaborator:
Theramed co.